RUBRA MEDICAMENTS LTD. - Statement Of Investor Complaints For The Quarter Ended March 31, 2017

Download	< Back
03 Apr 2017
Pursuant to Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Investor Grievance Redressal Report for the Quarter ended March 31, 2017 is as follows: DETAILS OF INVESTOR COMPLAINTS Pending at the beginning of the quarter Nil Received during the quarter Nil Disposed of during the quarter Nil Remaining unresolved at the end of the quarter Nil Please take note of the same.
View all announcements for RUBRA MEDICAMENTS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us